Form 8K Dyadic International Inc For: 30 March
- Investing.com
- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Dyadic International Inc (DYAI)
The Dyadic share price today is 0.860 %REPORT_CURRENCY%, view NASDAQ DYAI stock exchange data. Track the latest Dyadic share price with real-time updates on DYAI stock performance including market cap, day range, 52-week range and dividend yield. Access DYAI charts, earnings dates and analyst estimates to support your investment decisions.
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.831
0.930
52 wk Range
0.655
1.346
Earnings results expected in 12 days
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.8310.930
52 wk Range
0.6551.346
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
DYAI Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Strong Buy
Price Target
7.000
Upside
+713.95%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts do not anticipate the company will be profitable this year
- Form 8K Dyadic International Inc For: 6 March
- Investing.com
- Form 8K Dyadic International Inc For: 30 March
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Neutral
Moving Averages
Sell
Dyadic International, Inc., together with its subsidiaries, a biotechnology platform company, develops, manufactures, and commercializes proteins and enzymes in the United States. The company offers Dapibus Protein Production Platform, a proprietary expression system designed to produce non-animal proteins and enzymes for non-pharmaceutical markets, including life sciences, food and nutrition, and bio-industrial sector; and C1 Protein Production Platform, a thermophilic fungal platform for large-scale production of proteins. It has a research and development agreement with VTT Technical Research Centre of Finland, Ltd; license agreement with Rubic One Health to develop various livestock vaccines; and sub-license agreement with Phibro Animal Health/Abic Biological Laboratories to develop vaccines and treatments for livestock diseases. Dyadic International, Inc. was founded in 1979 and is headquartered in Jupiter, Florida.
Dyadic International Inc Earnings Call Summary for Q4/2025
- Q4 2025 revenue fell 11.7% to $3.09M as R&D collaboration declined, though grant revenue from Gates Foundation and CEPI partnerships increased.
- Operating loss widened to $7.19M from $5.9M in 2024; net loss reached $7.36M ($0.23/share) as company invests in commercialization transition.
- Cash position of $8.6M provides runway into 2027; ATM facility established for flexible capital access to support strategic initiatives.
- FY2026 revenue guidance set at $7.4M, driven by life sciences, food/nutrition, and bio-industrial segments as company shifts to commercial focus.
- Stock rose 3.32% to $0.845 post-earnings; analysts bullish with $5-$9 price targets despite 37% decline over past year.
Last Updated: 26-03-2026, 03:32 am
Read Full TranscriptCompare DYAI to Peers and Sector
Metrics to compare | DYAI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipDYAIPeersSector | |
|---|---|---|---|---|
P/E Ratio | −4.3x | −1.3x | −0.5x | |
PEG Ratio | 0.31 | −0.32 | 0.00 | |
Price/Book | 25.4x | 3.8x | 2.6x | |
Price / LTM Sales | 10.1x | 44.8x | 3.2x | |
Upside (Analyst Target) | - | 55.3% | 47.4% | |
Fair Value Upside | Unlock | 2.2% | 7.7% | Unlock |
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 7.000
(+713.95% Upside)
Earnings
Latest Release
25-03-2026
EPS / Forecast
-0.04 / -0.04
Revenue / Forecast
564.35K / 1.44M
FAQ
What Is the Dyadic (DYAI) Share Price Today?
The Dyadic share price today is 0.860 USD.
What is the current Dyadic (DYAI) share price and day range?
As of 25-04-2026, the Dyadic share price is 0.860 USD, with a previous close of 0.866 USD. The share price has ranged from 0.831 to 0.930 USD today, while the 52-week range spans from 0.655 to 1.346 USD.
What Is the Dyadic Market Cap?
As of today, Dyadic market cap is 31.340M.
What Is the Dyadic (DYAI) Share Price Target?
The average 12-month share price target for Dyadic is 7.000 USD, with a high estimate of 9 USD and a low estimate of 5 USD. 1 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +713.95% Upside potential.
What Is Dyadic's Earnings Per Share (TTM)?
The Dyadic EPS (TTM) is -0.226.
When Is the Next Dyadic Earnings Date?
Dyadic will release its next earnings report on 07-05-2026.
From a Technical Analysis Perspective, Is DYAI a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
What Stock Exchange Does Dyadic Trade On?
Dyadic is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Dyadic?
The stock symbol for Dyadic is "DYAI."
How Many Times Has Dyadic Stock Split?
Dyadic has split 0 times.
How Many Employees Does Dyadic Have?
Dyadic has 6 employees.
What Is the DYAI Premarket Price?
DYAI's last pre-market stock price is 0.849 USD. The pre-market share volume is 500.000, and the stock has changed by -0.017 USD, or -1.960%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.